Overactive Bladder - Results from #1300

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature April 19, 2016

Persistence of solifenacin therapy in patients with overactive bladder in the clinical setting: a prospective, multicenter, observational study April 19, 2016

Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder April 19, 2016

Long-term efficacy of a combination therapy with an anticholinergic agent and an α1-blocker for patients with benign prostatic enlargement complaining both voiding and overactive bladder symptoms: A randomized, prospective, comparative trial using a urody April 19, 2016

Urethroplasty Improves Overactive Bladder Symptoms in Men with Anterior Urethral Strictures April 19, 2016

A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder April 18, 2016

Gender differences in overactive bladder April 4, 2016

Electrical stimulation with non-implanted electrodes for overactive bladder in adults April 4, 2016

Efficacy and Safety of Propiverine Hydrochloride for Overactive Bladder in Adult: a Systematic Review and Meta-analysis April 3, 2016

Persistence and compliance with medication management in the treatment of overactive bladder April 3, 2016

Systemic Non-Urologic Symptoms in Patients with Overactive Bladder April 1, 2016

Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE) March 31, 2016

A drug safety evaluation of mirabegron in the management of overactive bladder March 29, 2016

The efficacy and tolerability of mirabegron in a non-trial clinical setting March 29, 2016

New Life in Overactive Bladder: "Novel regulatory mechanism in human urinary bladder: central role of TRPM4 channels in detrusor smooth muscle function" March 29, 2016

The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women March 2, 2016

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison March 1, 2016

Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study February 22, 2016

Treatment of fecal retention is important in the management of overactive bladder in children February 9, 2016

Botulinum toxin as a treatment for refractory overactive bladder February 3, 2016

Page 66 of 122